Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With RecurrentClostridioides difficileInfection Treated With Fecal Microbiota Transplantation or Antibiotics | Zendy

Gianluca Ianiro | Zendy; Rita Murri | Zendy; Giusi Desirè Sciumè | Zendy; Michele Impagnatiello | Zendy; Luca Masucci | Zendy; Alexander C. Ford | Zendy; Graham Law | Zendy; Herbert Tilg | Zendy; Maurizio Sanguinetti | Zendy; Roberto Cauda | Zendy; Antonio Gasbarrini | Zendy; Massimo Fantoni | Zendy; Giovanni Cammarota | Zendy

Open Access

Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With RecurrentClostridioides difficileInfection Treated With Fecal Microbiota Transplantation or Antibiotics

Author(s) -

Gianluca Ianiro,

Rita Murri,

Giusi Desirè Sciumè,

Michele Impagnatiello,

Luca Masucci,

Alexander C. Ford,

Graham Law,

Herbert Tilg,

Maurizio Sanguinetti,

Roberto Cauda,

Antonio Gasbarrini,

Massimo Fantoni,

Giovanni Cammarota

Publication year - 2019

Publication title -

annals of internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.839

H-Index - 390

eISSN - 1539-3704

pISSN - 0003-4819

DOI - 10.7326/m18-3635

Subject(s) - medicine , antibiotics , propensity score matching , prospective cohort study , cohort , incidence (geometry) , clinical endpoint , cohort study , transplantation , clostridium difficile , surgery , randomized controlled trial , physics , optics , microbiology and biotechnology , biology

Clostridioides difficile infection (CDI) is a risk factor for bloodstream infection (BSI). Fecal microbiota transplantation (FMT) is more effective than antibiotics in treating recurrent CDI, but its efficacy in preventing CDI-related BSI is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research